Next-Generation Degrader Antibody Conjugates

  • Our next-generation Degrader Antibody Conjugates (DAC) are designed to improve safety and efficacy through advanced antibody and linker engineering
  • DACs combine the tissue selectivity of antibody-mediated delivery with the well-validated catalytic mechanism of targeted protein degradation
  • DACs offer opportunities to expand beyond conventional cytotoxic ADC payloads